![NKGen Biotech, Inc. - Warrants](https://cdn-p0.s3.eu-central-1.amazonaws.com/logos/fallback/1.png)
NKGen Biotech, Inc. - Warrants
Share · US65488A1198 · NKGNW (XNAS)
0,08 USD
06.02.2025 21:39
Current Prices from NKGen Biotech, Inc. - Warrants
Exchange | Ticker | Currency | Last Trade | Price | Daily Change | Daily Change % |
---|---|---|---|---|---|---|
![]() NASDAQ |
NKGNW
|
USD
|
06.02.2025 21:39
|
0,08 USD
| 0,11 USD | -29,89 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 6,67 % | -20,00 % | 218,73 % | -11,11 % | -8,57 % | -73,33 % |
Company Profile for NKGen Biotech, Inc. - Warrants Share
Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.
Company Data
Name NKGen Biotech, Inc. - Warrants
Company NKGen Biotech, Inc. Warrants
Symbol NKGNW
Website https://www.grafacq.com
Primary Exchange
NASDAQ
![XNAS](https://cdn-p0.s3.eu-central-1.amazonaws.com/mic/XNAS.png)
ISIN US65488A1198
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Paul Y. Song M.D.
Country United States of America
Currency USD
Employees 0,1 T
Address 1790 Hughes Landing Boulevard, 77380 The Woodlands
ID Changes
Date | From | To |
---|---|---|
02.10.2023 | GFOR.W | NKGNW |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | NKGNW |
More Shares
Investors who NKGen Biotech, Inc. - Warrants hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.